Genomic Drug Discovery Startup Warp Drive Launches with $125M from Sanofi, Other Backers | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Warp Drive Bio, a new firm that plans to apply a "genomic search engine" to identify new drugs in microbes, kicked off today with $125 million in initial financing from Sanofi, Third Rock Ventures, and Greylock Partners.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.